Company Monitoring Page for Boehringer-Ingelheim

latest headlines for company on cafepharma

Boehringer snaps up Pharmaxis liver disease drug
Pharma Times
Mon, 05/18/15 - 09:06 am
Tags:
Boehringer Ingelheim, Pharmaxis, NASH, PXS4728A
FDA warns on newer class of type 2 diabetes drugs
Yahoo/Reuters
Sat, 05/16/15 - 02:04 pm
Tags:
FDA, diabetes, type 2 diabetes, AstraZeneca, Farxiga, Eli Lilly, Jardiance, Boehringer Ingelheim, JNJ, Invokana, SGLT2 inhibitor
Big Pharma's cardiovascular sales ain't what they used to be
Fierce Pharma
Thu, 05/7/15 - 11:22 am
Tags:
Big Pharma, Boehringer Ingelheim, Novartis, Pfizer, AstraZeneca, Sanofi
It’s Been One of “Those Weeks” in Hatch-Waxman World: Another Two Lawsuits and Two Court Decisions
FDA Law Blog
Fri, 05/1/15 - 10:11 am
Tags:
FDA, Hatch Waxman Act, Spectrum Pharmaceuticals, Boehringer Ingelheim, Otsuka
FDA gives Boehringer's Pradaxa antidote a boost with fast-track review
Fierce Pharma
Thu, 04/23/15 - 01:34 pm
Tags:
FDA, Boehringer Ingelheim, fast track, Pradaxa, idarucizumab
Pharma's getting savvier about social, with Boehringer, Bayer leading the pack
Fierce Pharma Marketing
Wed, 04/22/15 - 09:48 am
Tags:
social media, Bayer, Boehringer Ingelheim
Boehringer posts flat earnings on stagnant Pradaxa sales
Yahoo/Reuters
Wed, 04/22/15 - 09:02 am
Tags:
Boehringer Ingelheim, earnings
J&J's Invokana fends off new SGLT2 rivals to hit $278M in Q1
Fierce Pharma Marketing
Wed, 04/15/15 - 09:28 am
Tags:
JNJ, Invokana, SGLT2 inhibitor, diabetes, Boehringer Ingelheim, Eli Lilly, Jardiance, Glyxambi
The largest biopharma layoffs of 2014
Fierce Pharma
Tue, 04/7/15 - 11:10 am
Tags:
layoffs, Amgen, Novartis, Allergan, GSK, Boehringer Ingelheim, Actavis, AstraZeneca
Psoriasis data wars heat up at AAD with Novartis, Boehringer studies
Fierce Pharma Marketing
Thu, 03/26/15 - 07:38 am
Tags:
Novartis, psoriasis, Boehringer Ingelheim, Pfizer, Xeljanz, Cosentyx, JNJ, Stelara, BI-655066, Amgen, AstraZeneca, Merck, Eli Lilly
Pradaxa antidote goes to FDA
Medical Marketing and Media
Mon, 03/2/15 - 04:40 pm
Tags:
Pradaxa, FDA, idaricizumab, Boehringer Ingelheim
Boehringer's sales slide triggers job-chopping in Connecticut
Fierce Biotech
Tue, 02/17/15 - 12:48 pm
Tags:
Boehringer Ingelheim, layoffs, Connecticut, R&D
FDA approves Boehringer-Lilly drug for type-2 diabetes patients
Yahoo/Reuters
Mon, 02/2/15 - 11:01 am
Tags:
FDA, Eli Lilly, Boehringer Ingelheim, diabetes, type 2 diabetes, Glyxambi
EC clears Boehringer Ingelheim's Ofev for idiopathic pulmonary fibrosis
First Word Pharma
Mon, 01/19/15 - 12:02 pm
Tags:
Boehringer Ingelheim, Ofev, IPF, idiopathic pulmonary fibrosis, Europe
Sanofi, BI Enter Manufacturing Collaboration for Biologics
Drug Discovery and Development
Mon, 01/19/15 - 11:57 am
Tags:
Sanofi, Boehringer Ingelheim, R&D, biologics
Boehringer Ingelheim Weighs Sale of U.S. Generics Business Roxane Labs
TheStreet.com
Thu, 01/15/15 - 12:07 pm
Tags:
generics, M&A, Boehringer Ingelheim, Roxane Laboratories
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Tags:
Europe, AbbVie, hepatitis C, dasabuvir, Sanofi, eliglustat, Novartis, secukinumab, Merck, Vorapaxar, Boehringer Ingelheim, nintedanib
Boehringer taps WellPoint's outcomes data to develop new a-fib drugs
Fierce Biotech
Fri, 11/14/14 - 11:03 am
Tags:
Boehringer Ingelheim, Wellpoint, atrial fibrillation, R&D, clinical outcomes
Pradaxa antidote enters Phase III
Medical Marketing and Media
Tue, 11/11/14 - 10:44 am
Tags:
Pradaxa, Boehringer Ingelheim
A tale of two studies: Prescribe Pradaxa 'with caution'? Or rely on FDA's safety backing?
Fierce Pharma Marketing
Thu, 11/6/14 - 08:58 am
Tags:
Pradaxa, Boehringer Ingelheim, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.